Related to Gamma Partners with Health Diagnostic Lab to Develop Risk Assay for Heart Attack and Stroke

• FDA Gives Arbor Vita’s Avian Flu Test the Go-Ahead
  
• Prometheus Gains U.S. Rights to Rosetta's Cancer Tests
  
• Two Genetic Variants Tied to Increased Stroke Risk
  
• Clarient Acquires Breast Cancer Biomarker from Indiana University
  
• Sequenom Reduces Workforce in Genetic Analysis Unit
  
• Epigenomics Grants Predictive Biosciences Rights to Use a Biomarker in a Prostate Cancer Test
  
• Genetic Profile Found that Predicts Best Chemotherapy for Ovarian Cancers
  
• Alethia Licenses Preclinical Cancer mAbs for Drug and Diagnostic Development
  
• Diatherix Releases Swine Flu Virus Test
  
• Roche Launches Swine Flu Detection Kit for Research Purposes
  
• Collaboration Formed to Evaluate Epigenomics’ Test in Detecting Colorectal Polyps
  
• Proteome Sciences Inks Deal with Axela to Develop Brain-Damage Biomarker Assays
  
• Blanchette Rockefeller Neurosciences Institute and Inverness Join Forces for Alzheimer's Diagnostic
  
• ExonHit Licenses IP for Breast Cancer Test from Institut Gustave Roussy
  
• Interleukin Genetics Introduces Weight Management Genetic Test
  
• Exact Sciences Closes $8.2M Placement and Inks Deal with Mayo Clinic
  
• Axis-Shield Acquires Rights to Develop Sepsis Diagnostic from Hansa Medical
  
• Swiss Viollier to Launch Colorectal Cancer Blood Test in Europe
  
• Castle Biosciences Chooses Phoenix Hospital to Offer Its Molecular Diagnostic for Brain Cancer
  
• GE Healthcare and Geron to Co-Develop hESC-Derived Assay Products